Smith+Nephew Acquires Integrity Orthopaedics

Smith+Nephew acquired Integrity Orthopaedics, a U.S.‑based early‑stage commercial developer of the Tendon Seam rotator cuff repair system designed to reduce re‑tear rates and improve patient outcomes.

Smith+Nephew will make an initial cash payment of USD $225 million plus additional performance-based payments of up to $225 million over the next five years. The transaction is to close before the end of January 2026.

Tendon Seam’s micro‑anchors, continuous suture, individually locked stitches, and integrated implantation instrument are designed to deliver stronger repairs, accelerated patient recovery, lower re‑tear rates, and a simplified surgical technique. Early clinical experience indicates low re‑tear rates, reduced sling times and shorter procedures compared with standard methods. The system received 510(k) clearance in 2023 and is indicated for reattachment of soft tissue to bone, including tendons, ligaments, and joint capsules.

Integrity Orthopaedics was founded in 2020 and is headquartered in Maple Plain, Minnesota. Its founders include Tom Westling, co-founder of Rotation Medical, the developer of the REGENETEN Bioinductive Implant, which was acquired by Smith+Nephew in 2017.

Scott Schaffner, President Sports Medicine, Smith+Nephew, said, “Smith+Nephew now has an unrivalled portfolio for shoulder, including a powerful next‑generation rotator cuff repair platform to complement market-leading biological augmentation, the newest shoulder arthroplasty system, and proven solutions across shoulder instability. We welcome the Integrity team, including those involved with our prior successful acquisition of Rotation Medical, and look forward to working together again to offer customers and their patients this exciting technology.”

Source: Smith+Nephew